首页 | 本学科首页   官方微博 | 高级检索  
     


Survival benefit with the combination of docetaxel, gemcitabine and erlotinib in advanced and/or metastatic pancreatic cancer patients
Authors:Samelis Georgios F  Ekmektzoglou Konstantinos  Tsiakou Andriani  Giannakaki Styliani  Konstadoulakis Manoussos
Affiliation:Oncology Department, University of Athens, Medical School, Greece. gsamelis@otenet.gr
Abstract:
Keywords:
本文献已被 PubMed 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号